501 related articles for article (PubMed ID: 34916412)
1. Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia.
Charif SE; Vassallu MF; Salvañal L; Igaz LM
Neural Regen Res; 2022 Jul; 17(7):1423-1430. PubMed ID: 34916412
[TBL] [Abstract][Full Text] [Related]
2. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients.
Scialò C; Tran TH; Salzano G; Novi G; Caponnetto C; Chiò A; Calvo A; Canosa A; Moda F; Caroppo P; Silani V; Ticozzi N; Ratti A; Borroni B; Benussi L; Ghidoni R; Furlanis G; Manganotti P; Senigagliesi B; Parisse P; Brasselet R; Buratti E; Legname G
Brain Commun; 2020; 2(2):fcaa142. PubMed ID: 33094285
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
[TBL] [Abstract][Full Text] [Related]
5. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
6. Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia.
Pasetto L; Grassano M; Pozzi S; Luotti S; Sammali E; Migazzi A; Basso M; Spagnolli G; Biasini E; Micotti E; Cerovic M; Carli M; Forloni G; De Marco G; Manera U; Moglia C; Mora G; Traynor BJ; Chiò A; Calvo A; Bonetto V
Brain; 2021 Dec; 144(12):3710-3726. PubMed ID: 34972208
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 cytoplasmic inclusion formation is disrupted in
Lee SM; Asress S; Hales CM; Gearing M; Vizcarra JC; Fournier CN; Gutman DA; Chin LS; Li L; Glass JD
Brain Commun; 2019; 1(1):fcz014. PubMed ID: 31633109
[TBL] [Abstract][Full Text] [Related]
8. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.
Kalmar B; Lu CH; Greensmith L
Pharmacol Ther; 2014 Jan; 141(1):40-54. PubMed ID: 23978556
[TBL] [Abstract][Full Text] [Related]
9. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
Ratti A; Buratti E
J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
[TBL] [Abstract][Full Text] [Related]
10. MRI-guided histology of TDP-43 knock-in mice implicates parvalbumin interneuron loss, impaired neurogenesis and aberrant neurodevelopment in amyotrophic lateral sclerosis-frontotemporal dementia.
Lin Z; Kim E; Ahmed M; Han G; Simmons C; Redhead Y; Bartlett J; Pena Altamira LE; Callaghan I; White MA; Singh N; Sawiak S; Spires-Jones T; Vernon AC; Coleman MP; Green J; Henstridge C; Davies JS; Cash D; Sreedharan J
Brain Commun; 2021; 3(2):fcab114. PubMed ID: 34136812
[TBL] [Abstract][Full Text] [Related]
11. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia.
Thumbadoo KM; Dieriks BV; Murray HC; Swanson MEV; Yoo JH; Mehrabi NF; Turner C; Dragunow M; Faull RLM; Curtis MA; Siddique T; Shaw CE; Newell KL; Henden L; Williams KL; Nicholson GA; Scotter EL
Brain; 2024 May; ():. PubMed ID: 38703371
[TBL] [Abstract][Full Text] [Related]
13. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.
Nishimura AL; Zupunski V; Troakes C; Kathe C; Fratta P; Howell M; Gallo JM; Hortobágyi T; Shaw CE; Rogelj B
Brain; 2010 Jun; 133(Pt 6):1763-71. PubMed ID: 20472655
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways.
Barmada SJ; Finkbeiner S
Rev Neurosci; 2010; 21(4):251-72. PubMed ID: 21086759
[TBL] [Abstract][Full Text] [Related]
15. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R; Neumann M
Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
[TBL] [Abstract][Full Text] [Related]
17. Synaptopathy: presynaptic convergence in frontotemporal dementia and amyotrophic lateral sclerosis.
Clayton EL; Huggon L; Cousin MA; Mizielinska S
Brain; 2024 Mar; ():. PubMed ID: 38451707
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM
Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
Geser F; Lee VM; Trojanowski JQ
Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
